Volume : 09, Issue : 02, February – 2022

Title:

12.PREVALENCE AND PREDICTORS OF DEPRESSION AMONG ACNE PATIENTS ATTENDING DERMATOLOGY CLINIC IN HOSPITALS OF MINISTRY OF HEALTH, TAIF CITY, SAUDI ARABIA, 2021

Authors :

Dr. Saleh Mousa Alkathiri, Dr. Mohammed Daifallah Alzaydi

Abstract :

Background: Acne vulgaris is a common dermatological disease with a prevalence reaching up to 80% in the second and third decades of life. The psychological impact of acne on patients is significant. The co-existence of acne and depression is a complex issue and, in adolescence, can be associated with developmental outcomes of body image, socialization and sexuality. Since lack of previous literature in the province, this study aims to study the possible association between acne vulgaris and depression and factors affecting that association in Taif, KSA. Methods: This is a cross-sectional study. All acne patients attended dermatology outpatient clinics in the two hospitals (King Abdulaziz specialized and King Faisal) throughout the period of the study (January-March, 2021) were eligible for inclusion in the study. Patients with concomitant dermatological disorder and/or psychiatric diseases were excluded from the study.
Data was collected using a self-administered questionnaire and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). Results and conclusion: The study included 230 subjects aged 18-43 years with mean (SD) age of 25.5 (6.0). Females comprised 61.3% of participants. The prevalence of depression (combining the last three severity groups) among subjects with acne vulgaris in Taif, KSA is 41.4%. The severity of acne was strongly associated to the severity of depression, as well as the type of acne treatment was linked with depression severity, with participants receiving oral, or oral and topical treatment having more severe depression types than those who did not get treatment.

Cite This Article:

Please cite this article in press Saleh Mousa Alkathiri et al, Prevalence And Predictors Of Depression Among Acne Patients Attending Dermatology Clinic In Hospitals Of Ministry Of Health, Taif City,
Saudi Arabia, 2021., Indo Am. J. P. Sci, 2022; 09(2).

Number of Downloads : 10

References:

1. Rzany B, Kahl C. Epidemiology of acne vulgaris. J Dtsch Dermatol Ges 2006; 4(1):8-9.
2. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2012;379:361–72.
3. Kokandi A. Evaluation of Acne quality of life and clinical severity in Acne female adults. Dermatology Research and Practice. 2010; Volume 2010, Article ID 410809, 3 pages.
4. Tan JKL. Psychosocial impact of acne vulgaris: evaluating the evidence. Skin Therapy Letter 2004; 9(7):1–9.
5. Magin P, Adams J, Heading G, Pond D, Smith W. Psychological sequelae of acne vulgaris: results of a qualitative study. Canadian Family Physician 2006; 52(8): 978–979
6. Purvis D, Robinson E, Merry S, Watson P. Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students. Journal of Paediatrics and Child Health 2006;42(12):793–796.
7. Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. British Journal of Dermatology 1999;140(2): 273–282.
8. Rapp DA, Brenes GA, Feldman SR, Fleischer Jr AB, Graham GF, Dailey M, Rapp SR. Anger and acne: implications for quality of life, patient satisfaction and clinical care. British Journal of Dermatology. 2004;151(1):183–189.
9. Dalgard F, Gieler U, Holm J, Bjertness E, Hauser S. Self-esteem and body satisfaction among late adolescents with acne: results from a population survey. Journal of the American Academy of Dermatology 2008;59(5):746–751.
10. Loney T, Standage M, Lewis S. Not just ‘skin deep’: psychosocial effects of dermatological-related social anxiety in a sample of acne patients. Journal of Health Psychology. 2008;13(1):47–54, 2008.
11. Uhlenhake E, Yentzer BA, Feldman SR. Acne vulgaris and depression: a retrospective examination. J Cosmet Dermatol 2010; 9(1):59-63.
12. Picardi A, Mazzotti E, Pasquini P. Prevalence and correlates of suicidal ideation among patients with skin disease. Journal of the American Academy of Dermatology. 2006;54(3):420–426.
13. Mleeh NT, Alshamrani HM, Basyouni RN, Alshehri KA, Algethami MR, Sehlo MG. Prevalence and predictors of depression among dermatology clinic patients in a teaching hospital, Jeddah, Saudi Arabia. J Family Med Prim Care 2019;8:2496-501
14. Al-Huzali SMA, Al-Malki KS, Al-Nikhali SAS, Al-Matrafi KAM. Prevalence of depression among acne patients in King Faisal Hospital and King Abulaziz Hospital in Makkah, Saudi Arabia. Int J Med Sci Public Health. 2014; 3(9): 1150-1156
15. Vallerand I, Lewinson RT, Parsons L, Lowerison M. Risk of depression among patients with acne in the U.K.: a population-based cohort study. Br J Dermatol. 2018 Mar;178(3):e194-e195. doi: 10.1111/bjd. 16099.
16. Li C, Chen J, Wang W, Ai M, Zhang Q, Kuang L. Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta- analysis. BMJ Open 2019;9:e021549. doi:10.1136/bmjopen-2018- 021549
17. Dharshana S, Singh AK, Sharma S, Mohan SK, Joshi A. Depression, mood change and self-esteem among adolescents aged 12-25 years with acne vulgaris in India. Ann Trop Med Public Health 2016;9:31-6
18. Duman H, Topal IO, Kocaturk E, Duman MA. Evaluation of anxiety, depression, and quality of life in patients with acne vulgaris, and quality of life in their families. Dermatologica Sinica 2016; 34:6-9
19. Bashir K, Dar NR, Rao SU. Depression in adult dermatology outpatients. Journal of the College of Physicians and Surgeons Pakistan 2010; 20 (12): 811-813
20. Shakoor A, Shaheen JA, Khan JI. Association of anxiety and depression with acne: evaluation of pathoplastic effect of adolescence on this comorbidity. Journal of Pakistan Association of Dermatologists 2012;22 (4):336-341.
21. Yazici K, Baz K, Yazici AE, Kokturk A, Tot S, Demirseren D, et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol 2004; 18(4):435-9.
22. Purvis D, Robinson E, Merry S, Watson P. Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students. Journal of Paediatrics and Child Health 2006; 42(12):793–796.
23. Uhlenhake E, Yentzer BA, Feldman SR. Acne vulgaris and depression: a retrospective examination. J Cosmet Dermatol 2010; 9(1):59-63.
24. Kingdom of Saudi Arabia. Taif Governorate. Available at: http://www.taifcity.gov.sa.
25. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, LeydenJJ, Shalita AR, Thiboutot D. Management of acne: a reportfrom a global alliance to improve outcomes in acne.JAmAcad Dermatol2003;49(1 Suppl): S1–37.
26. Kilkenny M, Merlin K, Plunkett A, Marks R. The preva-lence of common skin conditions in Australian schoolstudents: 3. acne vulgaris.Br J Dermatol1998;139:840–5.
27. James WD. Clinical practice. Acne. N Engl J Med 2005; 352 (14): 1463–72.
28. Bartlett JE, Kotrlik JW, Higgins CC. Organizational Research: Determining Appropriate Sample Size in Survey Research. Information Technology, Learning, and Performance Journal 2001; 19(1):43-50.
29. Liu SI, Yeh ZT, Huang HC, Sun FJ, Tjung JJ, Hwang LC, Shih YH, Yeh AW. Validation of Patient Health Questionnaire for depression screening among primary care patients in Taiwan. Compr Psychiatry. 2011;52(1):96-101.
30. AlHadi AN, AlAteeq DA, Al-Sharif E, Bawazeer HM, Alanazi H, AlShomrani AT, et al. An Arabic translation, reliability, and validation of Patient Health Questionnaire in a Saudi sample. Ann Gen Psychiatry. 2017; 16: 32. doi: 10.1186/s12991-017-0155-1
31. Arroll B, Goodyear-Smith F, Crengle S, Gunn J, Kerse N, Fishman T, Falloon K, Hatcher S. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med. 2010;8(4):348-53.